Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CK18 as a potential predictor of type 2 diabetes in patients with NAFLD

Oct. 21, 2014

Cystic fibrosis candidate N-6022 well tolerated in phase I study

Oct. 21, 2014

HMB-45 staining increases after UVB treatment for vitiligo

Oct. 21, 2014

Results from the first study of fidaxomicin in pediatric patients with CDAD

Oct. 21, 2014

Interim analysis of PUNCH-CD trial results demonstrate safety and efficacy of RBX-2660

Oct. 20, 2014

Results from PIONEER II trial of adalimumab in the treatment of hidradenitis suppurativa

Oct. 20, 2014

Phase I results for the new prolonged-duration local anesthetic, neosaxitoxin

Oct. 20, 2014

Phase II cystic fibrosis candidate NVP-QBW-251 data reported

Oct. 20, 2014

Serotonin receptor polymorphisms studied in patients with refractory depression

Oct. 20, 2014

Identification of a novel nuclear-encoded mitochondria susceptibility loci for schizophrenia

Oct. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...